TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsSujal Patel - Co-Founder, ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline catalysts.

OmniAb, Inc. (NASDAQ:OABI) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good afternoon, and welcome to OmniAb, Inc.’s First — Fourth Quarter 2025 Financial Results and Business Update ...

COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ('COSCIENS” or the 'Company”) today announced that the Company has made a strategic decision to cease funding its German subsidiaries, Aeterna ...

COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company") today announced that the Company has made a strategic decision to ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

There has traditionally been a comforting certainty that healthcare companies provide ballast in a portfolio. It was long ...